Athira Pharma Inc. (ATHA) Prices 4M Share Common Offering at $22.50/Sh

Athira Pharma, Inc., (NASDAQ: ATHA) today announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a public offering price of $22.50 per share. All of the shares of common stock are being offered by Athira. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Athira, are expected to be $90.0 million. The offering is expected to close on January 25, 2021, subject to satisfaction of customary closing conditions. In addition, Athira has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock at the public offering price less underwriting discounts and commissions.

Goldman Sachs & Co. LLC, Jefferies and Stifel are acting as joint book-running managers for the offering. JMP Securities is acting as co-manager.

A registration statement relating to the offering has been filed with the Securities and Exchange Commission and became effective on January 20, 2021. The offering is being made only by means of a prospectus.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Andersen closes secondary offering of 4.9M shares at $44 each
• Silexion Therapeutics faces Nasdaq delisting over equity shortfall